Background and Aims: Background: Duchenne muscular dystrophy (DMD) is characterized as progressive muscle wasting and eventually results in respiratory insufficiency. Obstructive sleep apnoea (OSA) and hypoventilation were prevalent in DMD. Nevertheless, nocturnal hypoventilation (NH) has been associated with respiratory failure in DMD. Although early identifying OSA and NH may facilitate early treatment but clinical associated factors have not been fully elucidated.
effective than CPAP. Positional device has been shown to be effective in some OSA patients and combination therapy might have synergistic effects.
Methods: Position dependent OSA is defined as the overall AHI > 5/h and the supine AHI more than 2 times of AHI in other positions. Patients with positional dependent OSA who were not using CPAP were put on a positional device (Figure 1 , NightShiftTM, Advanced Brain Monitoring Inc., CA, USA). It uses vibro-tactile feedback to discourage backsleeping. Patients using MAD with a residual AHI > 15/h were offered positional device as combination treatment. Both groups of patients had the device switched on and off for 2 weeks respectively with one week of wash out period in between. Sleep studies were performed after the end of each 2 weeks period.
Results: Between January 2015 to December 2017, 54 patients completed a trial of positional device, of which 8 patients were using MAD at the same time. There was no significant difference between the two groups on baseline mean age (55/58), BMI (27/27), ESS (9/9) and AHI (23/25). Table 1 shows outcomes of the two groups. Up to 89% of patients were woke up by the vibration 47% could not fall asleep again.
Conclusion:
Non CPAP combination therapy is feasible and effective in selected patients. Background and Aims: Excessive daytime sleepiness (EDS) is due to variable causes. Most patients, after a thorough clinical assessment, need a polysomnography to come to a correct diagnosis. This study is to explore the demographic profile of patients with EDS and any correlation with patients' profile.
Methods: This was a retrospective study looking at patients with EDS attending the Sleep Clinic in Hospital Taiping from April 2017 till February 2018. The data was retrieved from the outpatient notes and analyzed with SPSS version 21. Mann-Whitney U test was used to explore the association between the different parameters. Patients with an Epworth Sleepiness Score of more than 12 were included. All patients underwent a full night attended polysomnogram. Patients' age, ethnicity, comorbidities, BMI and sleep diagnosis were analyzed.
Results: 105 patient's data were analyzed, 61% were male and 39% were female. 61.9% were Malays, 12.4% were Chinese and 25.7% were Indians. Male patients had more severe OSA compared to females, which was statistically significant. 90.5% of patients were obese. 20% of patients had mild OSA, 15.2% had moderate OSA and 58.1% had severe OSA, 2.9% had primary central sleep apnoea, 1% had idiopathic hypersomnia, 1% had Cheyne Stoke Respiration and 2% had narcolepsy. 61.5% of male patients and 38.5% of female patients had OSA with obesity hypoventilation syndrome (OHS). All the patients with OHS had OSA. 59.1% of patients with severe OSA had hypertension and 85.7% of patients had both hypertension and diabetes mellitus. There was a statistically significant increase in the co-morbidities in patients with severe OSA compared to mild and moderate OSA.
Men develop more severe OSA than women. Patients with severe OSA were more likely to have hypertension and diabetes compared to non-severe OSA. Hence early diagnosis is essential to prevent complications.
